Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 319 clinical trials
None
Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients

The primary objective of this study is to evaluate the current management approach with "intermediate" or "therapeutic" doses of tinzaparin for thromboprophylaxis in hospitalized patients, non on ICU organ support, with confirmed COVID-19.

  • 0 views
  • 17 Sep, 2021
  • 3 locations
None
COVID-19 in Pediatric Oncology and Hematology Centers in France

Since the description of the first cases of infection in December 2019 in the Hubei province in China, a new coronavirus, called SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), emerged and caused a pandemic. This new virus is responsible for an infectious disease with respiratory and potent severe symptoms, called …

SARS
diarrhea
leukemia
fatigue
immunosuppressive agents
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Kidney in Coronavirus Disease 2019 Registry

The SARS-CoV-2 virus is a virus newly identified in January 2020. The WHO defined COVID-19 as a health emergency of international importance. The clinical manifestation of the COVID-19 disease cannot be fully described in the short time. First insights in patients suffering from acute kidney injury (AKI) during COVID-19 indicate …

  • 0 views
  • 24 Mar, 2021
  • 1 location
None
The Role of Bacterial Toxins in Human Skin Disease

Atopic dermatitis and psoriasis are two skin diseases often associated with bacterial infections and inflammation. Studies indicate that skin cells from these patients may have some changes that make these patients more susceptible to bacterial infections. Inflammatory environment may have an effect on the function of skin cells. The purpose …

bacterial infection
elidel
cyclosporine
skin biopsy
antibiotics
  • 269 views
  • 20 Oct, 2021
  • 1 location
None
Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome

This study aims to find out whether the use of angiotensin II, which is a drug to raise blood pressure has been approved by European Medical Agency in August 2019, as an add-on medication to increase blood pressure in patients with COVID-19, acute severe lung injury, inflammation and severe shock, …

norepinephrine
acute respiratory distress
lung injury
angiotensin
shock
  • 0 views
  • 15 Aug, 2021
  • 1 location
None
SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19)

Overall mortality of COVID-19 is variable and has been reported to be between less than 1% and 7%. Many authors around the world also reported data on hospitalization rate, need for intensive care unit (ICU) care and need for mechanical ventilation in SARS-CoV-2 infected patients. To provide anesthetic and surgical …

SARS
mechanical ventilation
respiratory failure
fatigue
cough
  • 2 views
  • 29 Sep, 2021
  • 1 location
None
Covid-19: Possible Role of Neutrophil Extracellular Traps

The process by which neutrophils expel DNA together with various proteins to the outside, forming a network structure called Neutrophil Extracellular Traps (NETs) constitutes a particular cell death that involves the destruction of the nuclear membrane before the plasmatic one. This process is called NETosis and differs from other known …

hypercytokinemia
cytokine storm
acute respiratory distress
cytokines
covid-19
  • 0 views
  • 24 Jan, 2021
  • 1 location
None
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

The purpose of this study is to examine gene expression profiles by DNA microarray in patients who are responders and non-responders to interferon and ribavirin treatment for hepatitis C virus (HCV). Genes involved in inflammation and fibrosis and mediators of the Th-1 lymphocyte response will be looked for. It is …

chronic hepatitis
mono
fibrosis
interferon
ribavirin
  • 47 views
  • 07 Nov, 2020
  • 1 location
None
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

DESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease

pulmonary disease
covid-19
blood test
COPD
asthma
  • 35 views
  • 31 Aug, 2021
  • 1 location